COLLABORATE Grant Program: Supporting Ageing Adults Living with Rare Diseases

The COLLABORATE Grant Program, initiated by Pfizer and CanAge, aims to support innovative solutions for older adults living with rare diseases. This initiative focuses on enhancing clinical awareness to accelerate diagnosis, developing National Action Plans addressing unique challenges, and gathering evidence to advocate for healthcare policy changes. By fostering collaboration and innovation, the program seeks to improve the quality of life for ageing adults facing rare disease challenges.

Pfizer Inc.
Pfizer's purpose is breakthroughs that change patients’ lives. It was Charles Pfizer’s vision at the beginning and it holds true today.
COLLABORATE Grant Program: Supporting Ageing Adults Living with Rare Diseases
Pfizer and the CanAge are collaborating to offer a new grant opportunity seeking grant proposals for programs that seek to explore innovative approaches to persistent challenges impacting older adults living with rare diseases, including, but not limited to:
Accelerating time to diagnosis by increasing understanding of the symptoms (including the distinctions between ageing and illness) through enhanced clinical awareness and integration of genetic testing to identify underlying conditions earlier.Supporting development of National Action Plans on Rare Disease (RD) to including solutions for the specific challenges faced by older adults and communities ageing with RD. Gathering exisiting evidence to support advocacy for closing heatlhcare gaps and drive policy change.